Novo Nordisk targets five-plus blockbuster launches by 2030
CEO Mike Doustdar said at a Capital Markets Day in London that Novo Nordisk aims to launch more than five blockbuster drugs by 2030, and to deliver more than 150 billion Danish crowns (about $23 billion) in pipeline sales in 2035.
Story updates
09:13:56 AM UTC
SquawkNews
By Dominic ChoppingNovo Nordisk aims to launch several new blockbuster drugs in the next few years while expanding into further treatment areas, part of a new plan to revive growth that the Ozempic manufacturer outlined at an investor event in London on Monday.In addition to at least five new "mult…
5096 Danish crowns)